The director of the NCI on cancer research and clinical trials during the COVID-19 pandemic

Cancer hasn’t stopped during this pandemic and neither has the National Cancer Institute or American Cancer Society. Ned Sharpless, MD, director of the National Cancer Institute, joined the TheoryLab podcast to talk about how we can sustain research momentum during the pandemic, what new research opportunities have arisen, and how clinical trials have been impacted. 2:57 – How his job has changed as a result of the coronavirus, and new tasks taken on by the NCI 5:09 – How we can sustain research momentum in the fight against cancer during this pandemic 8:57 – On why data sharing among scientists, always an NCI priority, has become even more important 11:02 – Several interesting cancer research opportunities that have arisen as a result of COVID-19 14:23 – How the pandemic has impacted clinical trials for cancer patients 19:48 – A message he’d like to share with cancer patients and their loved ones